Immunocore Holdings Plc (IMCR)
35.36
-0.77
(-2.13%)
USD |
NASDAQ |
Sep 08, 16:00
35.32
-0.04
(-0.11%)
After-Hours: 20:00
Immunocore Holdings Shareholders Equity (Quarterly) : 419.80M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 419.80M |
| March 31, 2026 | 393.67M |
| December 31, 2025 | 381.03M |
| September 30, 2025 | 396.56M |
| June 30, 2025 | 388.48M |
| March 31, 2025 | 378.48M |
| December 31, 2024 | 360.72M |
| September 30, 2024 | 377.83M |
| June 30, 2024 | 359.14M |
| March 31, 2024 | 359.53M |
| December 31, 2023 | 368.84M |
| September 30, 2023 | 355.84M |
| June 30, 2023 | 352.51M |
| March 31, 2023 | 338.90M |
| Date | Value |
|---|---|
| December 31, 2022 | 335.32M |
| September 30, 2022 | 329.11M |
| June 30, 2022 | 199.96M |
| March 31, 2022 | 215.01M |
| December 31, 2021 | 232.35M |
| September 30, 2021 | 272.21M |
| June 30, 2021 | 306.87M |
| March 31, 2021 | 339.13M |
| December 31, 2020 | 75.66M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 19.57M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Silence Therapeutics Plc | 38.47M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 26.89M |
| Mereo BioPharma Group Plc | 28.65M |
| Compass Pathways Plc | 84.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.119B |
| Total Liabilities (Quarterly) | 699.62M |
| Debt to Equity Ratio | 1.036 |
| Current Ratio | 4.469 |
| Net Debt Paydown Yield | -0.01% |